GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The Intersection of Metabolic and Reward Pathways Recent findings from the journal Addiction highlight a promising link ...

In a subgroup analysis, there was a positive effect in people with obesity, with significant reductions in brain reward center cue reactivity on functional magnetic resonance imaging. (HealthDay ...

Elon Musk has dished the secrets behind his recent weight loss transformation.

Participants taking tirzepatide also lost more body weight than those taking glucagon-like peptide-1 (GLP-1) receptor ...

Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when appropriately ...